Larvol Delta - Halozyme-and-Acumen-Pharmaceuticals-Enter-Global-Collaboration-and-NonExclusive-License-Agreement-for-the-ENHANZE-Technology-in-Alzheimer39s-Disease

ACU193 IV - Acumen Pharma

https://www.prnewswire.com/news-releases/halozyme-and-acumen-pharmaceuticals-enter-global-collaboration-and-non-exclusive-license-agreement-for-the-enhanze-technology-in-alzheimers-disease-301978022.html

Nov 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next